Trial Search Results
Enrollment on the Childhood Cancer Research Network (CCRN) of the Children s Oncology Group
The Children's Oncology Group has established a research network, the Childhood Cancer Research Network (CCRN), to collect information about children with cancer and other conditions that are benign but involve abnormal cell growth in order to help doctors and scientists better understand childhood cancer. The CCRN's goal is to collect clinical information about every child diagnosed with cancer and similar conditions in the United States and Canada, to allow researchers to study patterns, characteristics, and causes of childhood cancer. The information can also help researchers study the causes of childhood cancer.
Stanford is currently not accepting patients for this trial.
National Cancer Institute (NCI)
- INCLUSION CRITERIA:
- Pre-CCRN Entry
- All new patients seen in COG member institutions with any of the following diagnoses
- All cancer cases with an ICD-O histologic behavior code of two 2 (carcinoma in
situ)or three 3 (malignant).
- All lesions of the central nervous system regardless of behavior, i.e., benign,
borderline or malignant.
- The benign/borderline conditions which will be reportable by agreement shall
include: Mesoblastic nephroma, all teratomas, regardless of locations, Theca cell
- granulosa cell tumor, lymphoproliferative disease, ganglioneuroma,
myeloproliferative disease, Langerhan s Cell histiocytosis
Ages Eligible for Study
N/A - 18 Years
Genders Eligible for Study